Alan Sage

Alan Sage is the CEO and President of Vaporox Inc., a company focused on commercializing Vaporous Hyperoxia Therapy (VHT™) for treating chronic wounds.12 He has extensive experience in entrepreneurship and business leadership:

Professional Background

• Founded and led multiple startups, including Digabit Inc. (2010-2017) and Aftama Inc. (2008-2010)1
• Co-founded Configuresoft, which was acquired by EMC/VMware1
• Served as Interim President/COO at Bell ATM Service, Inc. (2018)1
• Executive Consultant at Sage Partners since 20071

Expertise

• Specializes in helping entrepreneurs fund, build, and sell companies1
• Experienced in SaaS, software development, IT, technology, asset management, e-commerce, and manufacturing1
• Skilled in raising capital, organizational growth, product management, and sales strategies1

Education

• Attended Colorado State University (1986-1991)1
• Completed personal development curriculum at Landmark (1993-2016)1

Current Role at Vaporox

As CEO and President, Alan Sage leads Vaporox in developing and commercializing VHT technology, which is FDA-510K-cleared for treating various skin wounds, including diabetic foot ulcers and pressure ulcers.12